Bloom, C. I., Yang, F. ., Hubbard, R. ., Majeed, A. ., & Wedzicha, J. A. (2024). Association of Dose of Inhaled Corticosteroids and Frequency of Adverse Events. Am J Respir Crit Care Med. http://doi.org/10.1164/rccm.202402-0368OC
pneumonia
Little, D. J., Arnold, M. ., Hedman, K. ., Sun, P. ., Haque, S. A., & James, G. . (2023). Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data. BMC Nephrol, 24, 91. http://doi.org/10.1186/s12882-023-03119-z
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety. Int J Chron Obstruct Pulmon Dis, 17, 1975–1986. http://doi.org/10.2147/copd.s378486
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. Copd, 19, 133–141. http://doi.org/10.1080/15412555.2022.2045265
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety. Copd, 19, 109–117. http://doi.org/10.1080/15412555.2022.2035705